Matthew Habgood

Title: Matthew Habgood: Innovator in Calcium-Activated Chloride Channel Modulation

Introduction

Matthew Habgood is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of pharmacology, particularly in the modulation of calcium-activated chloride channels. With a total of 3 patents, his work focuses on developing compounds that can aid in treating respiratory diseases.

Latest Patents

Matthew's latest patents include innovative compounds characterized by a general formula that serves as positive modulators of the calcium-activated chloride channel (CaCC), specifically TMEM16A. These compounds are designed to be beneficial in treating various diseases and conditions that are influenced by the modulation of TMEM16A, especially respiratory ailments.

Career Highlights

Matthew is associated with Tmem16a Limited, where he continues to advance his research and development efforts. His work is pivotal in exploring new therapeutic avenues for respiratory conditions, showcasing his commitment to improving patient outcomes through innovative solutions.

Collaborations

Matthew collaborates with esteemed colleagues such as Stephen Collingwood and Clive Mccarthy. Their combined expertise enhances the research environment and fosters innovation within their projects.

Conclusion

Matthew Habgood stands out as a dedicated inventor whose work in calcium-activated chloride channel modulation holds promise for the treatment of respiratory diseases. His contributions are paving the way for future advancements in medical therapies.